Norges Bank Invests $4.96 Million in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Norges Bank purchased a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 46,290 shares of the biotechnology company’s stock, valued at approximately $4,960,000. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Loomis […]
Norges Bank purchased a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 46,290 shares of the biotechnology company’s stock, valued at approximately $4,960,000. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Loomis […]
